chr16-31092475-A-G

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The NM_024006.6(VKORC1):c.283+837T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.649 (AC=98,662) in the gnomAD database across 151,936 control chromosomes, including 33,452 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.8. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★★).

Frequency

Genomes: 𝑓 0.65 ( 33452 hom., cov: 31)

Consequence

VKORC1
NM_024006.6 intron

Scores

3

Clinical Significance

drug response reviewed by expert panel B:2O:1

Conservation

PhyloP100: -1.08

Publications

12 publications found
Variant links:
Genes affected
VKORC1 (HGNC:23663): (vitamin K epoxide reductase complex subunit 1) This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
VKORC1 Gene-Disease associations (from GenCC):
  • coumarin resistance
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • vitamin K-dependent clotting factors, combined deficiency of, type 2
    Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • vitamin K-dependent clotting factors, combined deficiency of, type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_024006.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.7999 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_024006.6. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

VKORC1 NM_024006.6
MANE Select
HGVSc / HGVSpc.283+837T>C
Exon rankIntron 2 of 2
intron
Prot: NP_076869.1UniProt: A0A0S2Z6I4Q9BQB6-1
VKORC1 NM_001311311.2
HGVSc / HGVSpc.367+308T>C
Exon rankIntron 3 of 3
intron
Prot: NP_001298240.1
VKORC1 NM_206824.3
HGVSc / HGVSpc.174-1133T>C
Exon rankIntron 1 of 1
intron
Prot: NP_996560.1UniProt: Q9BQB6-3A0A0S2Z5X7

Ensembl Transcripts

VKORC1 ENST00000394975.3
TSL:1MANE Select
HGVSc / HGVSpc.283+837T>C
Exon rankIntron 2 of 2
intron
Prot: ENSP00000378426.2UniProt: Q9BQB6-1
ENSG00000255439 ENST00000529564.1
TSL:4
HGVSc / HGVSpc.283+837T>C
Exon rankIntron 2 of 4
intron
Prot: ENSP00000431371.1UniProt: E9PLN8
VKORC1 ENST00000319788.11
TSL:1
HGVSc / HGVSpc.365+308T>C
Exon rankIntron 3 of 3
intron
Prot: ENSP00000326135.7UniProt: Q9BQB6-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.649
AC:98558
Hom:33404
AN:151818
Cov:31
GnomAD4 genome
AF: 0.649
AC:98662
Hom:33452
AN:151936
Cov:31
TOPMed (Bravo)
AF: 0.641
AC:169639
Hom:57045
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.618
AC:333291
Hom:105595
AN:539518
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.605
AC:1417
Hom:442
AN:2342
ChinaMAP Phase 1
AF: 0.0913
Denmark Genome
AF: 0.610
AC:183
AN:300
GenomeAsia100K
AF: 0.528
AC:1834
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0740
AC:533
AN:7234
Qatari Genome
AF: 0.511
AC:90
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0941
AC:11321
Hom:536
AN:120248
Turkish Variome
AF: 0.527
AC:814
Hom:219
AN:1546
UK10K
AF: 0.631
AC:4770
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0923
AC:827
Hom:45
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

ClinVar submissions
Significance:drug response
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
-
warfarin response - Dosage (1)

Computational Scores

AlphaGenome AVI
Uncertain13
BayesDel_noAF
Benign-0.86
CADD
Benign1.7
DANN
Benign0.64
GPN-Star LLR
N/A2.7
GPN-Star score
N/A-1.1
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-1.1
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.